Ignite Creation Date:
2024-05-06 @ 6:29 PM
Last Modification Date:
2024-10-26 @ 2:49 PM
Study NCT ID:
NCT05680818
Status:
RECRUITING
Last Update Posted:
2024-05-14
First Post:
2022-12-12
Brief Title:
Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
Sponsor:
Calcilytix Therapeutics Inc a BridgeBio company
Organization:
Calcilytix Therapeutics Inc a BridgeBio company
Organization Data
Organization:
Calcilytix Therapeutics Inc a BridgeBio company
Class:
INDUSTRY
Study ID:
CLTX-305-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Calcilytix Therapeutics Inc a BridgeBio company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None